Telsey Advisory analyst Dana Telsey raised the firm’s price target on Levi Strauss (LEVI) to $24 from $21 and keeps an Outperform rating on the shares. The company reported “impressive” fiscal Q2 results, beating expectations across the board, the analyst tells investors. The firm notes the company’s raised annual outlook is particularly encouraging as the company’s guidance now includes the expected impact from tariffs and mitigation efforts.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEVI:
- Morning Movers: Capricor Therapeutics plunges following CRL from FDA
- Video: Capricor plunges after CRL, Performance Foods up after seeing interest
- Levi Strauss price target raised to $24 from $20 at Stifel
- Levi Strauss price target raised to $19 from $16 at Morgan Stanley
- Levi Strauss price target raised to $23 from $18 at JPMorgan